29-Nov-2022 - sanofi-aventis Groupe

Sanofi moves into its new Paris global headquarters

The opening is part of a global program to modernize the Group's workspaces around the world

Sanofi has moved into its new global headquarters in the 17th arrondissement of Paris, at 46-48 Avenue de la Grande Armée. The 9,000m² site has been designed to foster new hybrid ways of working and allows the around 500 employees to better connect, collaborate, create and celebrate. The new headquarters, which incorporate the highest standards of energy efficiency, are a model of environmental sustainability. Each employee’s carbon footprint has been reduced by nearly 100% compared to the previous site.

Paul Hudson. Chief Executive Officer, Sanofi: “The opening of La Maison Sanofi is another step toward the modern healthcare company we strive to become. A company open to the world and that seeks to offer its people the best work environment to chase the miracles of science.”

The structure of the building, originally two separate buildings now merged, has been entirely preserved by architect Franklin Azzi with the aim of giving a new life to an existing building complex. The Art Nouveau and Art Deco façades as well as the original Eiffel pillars, witnesses of the pioneering spirit of Paris in the 1900s, are highlighted on each of the eight floors of the building, which is topped by a rooftop terrace accessible to all staff members.

Named La Maison Sanofi, the new building is intended to be as welcoming as ‘a home’. Hospitality codes have been adopted, from the personalized welcome to the catering spaces, not to mention the work floors with their collaborative zones and cocoon areas. The lighting changes throughout the day according to the brightness of the outside and the acoustics have been specifically designed to reduce street noise as much as possible. The eco-designed furniture and decoration were specifically studied and chosen in collaboration with Studios agency and contribute to the comfort of the spaces with the abundant use of warm colors, comfortable and sustainable materials, such as tables made from recycled glass bottles or floor coverings made from old fishing nets.

Sanofi's new headquarters incorporate state-of-the-art digital and collaborative resources, including the deployment of the latest video conferencing technologies for an immersive meeting experience. An app allows employees to manage their entire day, at their fingertips: informing them of their remote working days or their arrival on the site, accessing their locker, booking a room or catering services and being aware of La Maison Sanofi events. 

The opening of La Maison Sanofi is part of a global program to modernize the Group's workspaces around the world. Several sites housing Sanofi's global teams have recently been opened or renovated with the same spirit: the Cambridge Crossing site, near Boston, in the United States, the Gentilly Campus in the Paris, France region and the Carteret Campus in Lyon, France.

More about Sanofi-Aventis
  • News

    Sanofi to acquire Amunix immuno-oncology pipeline with next generation Conditionally Activated Biologics

    Sanofi announced that it has entered into an agreement to acquire Amunix Pharmaceuticals, Inc., an immuno-oncology company leveraging its proprietary, clinically validated XTEN® and innovative universal protease-releasable masking technology platform, Pro-XTENTM, to discover and develop tra ... more

    Sanofi to acquire Kadmon

    Sanofi has entered into a definitive merger agreement with Kadmon Holdings, Inc. a biopharmaceutical company that discovers, develops, and markets transformative therapies for disease areas of significant unmet medical needs. The acquisition supports Sanofi’s strategy to continue to grow it ... more

    Sanofi to acquire Translate Bio

    As part of Sanofi’s endeavor to accelerate the application of messenger RNA (mRNA) to develop therapeutics and vaccines, the company has entered into a definitive agreement with Translate Bio, a clinical-stage mRNA therapeutics company, under which Sanofi will acquire all outstanding shares ... more

  • Companies


    SIRION Biotech is Europe's leading commercial supplier of viral vectors used for genetic cell modelling, gene target validation and gene therapy- and vaccination studies. Since its foundation in 2007, SIRION’s mission has been to change the paradigm for viral vector supplies. It has the ab ... more